Welcome to LookChem.com Sign In|Join Free
  • or
Uridine, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-, 2',3'-bis(tetradecylcarbamate) is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

830322-90-2

Post Buying Request

830322-90-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

830322-90-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 830322-90-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,3,0,3,2 and 2 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 830322-90:
(8*8)+(7*3)+(6*0)+(5*3)+(4*2)+(3*2)+(2*9)+(1*0)=132
132 % 10 = 2
So 830322-90-2 is a valid CAS Registry Number.

830322-90-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 2',3'-di(tetradecylcarbamoyl)-5'-(4,4'-dimethoxytrityl)uridine

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:830322-90-2 SDS

830322-90-2Upstream product

830322-90-2Downstream Products

830322-90-2Relevant academic research and scientific papers

Functional synthetic molecules and macromolecules for gene delivery

-

Page/Page column 74-75, (2008/06/13)

The present invention describes a synthetic non-viral vector composition for gene therapy and the use of such compositions for in vitro, ex vivo and/or in vivo transfer of genetic material. The invention proposes a pharmaceutical composition containing 1) a non-cationic amphiphilic molecule or macromolecule and its use for delivery of nucleic acids or 2) a cationic amphiphilic molecule or macromolecule that transforms from a cationic entity to an anionic, neutral, or zwitterionic entity by a chemical, photochemical, or biological reaction and its use for delivery of nucleic acids. Moreover this invention describes the use of these non-viral vector compositions in conjunction with a surface to mediate the delivery of nucleic acids. An additional embodiment is the formation of a hydrogel with these compositions and the use of this hydrogel for the delivery of genetic material. A further embodiment of this invention is the use of a change in ionic strength for the delivery of genetic material.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 830322-90-2